A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of IC2000 and SPY Fluorescence Imaging Systems in the Identification of Lymph Nodes During Lymphatic Mapping in Subjects With Breast Cancer

Trial Profile

A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of IC2000 and SPY Fluorescence Imaging Systems in the Identification of Lymph Nodes During Lymphatic Mapping in Subjects With Breast Cancer

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2018

At a glance

  • Drugs IC 2000 (Primary)
  • Indications Breast cancer
  • Focus Diagnostic use; Registrational
  • Acronyms FILM-B
  • Sponsors Novadaq Technologies
  • Most Recent Events

    • 02 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Oct 2019.
    • 02 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2019.
    • 02 Feb 2018 Planned initiation date changed from 1 Sep 2017 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top